SAHPRA Traceability Requirements in South Africa: What Pharma Manufacturers Need to Know

SAHPRA Traceability: South Africa’s Pharmaceutical Industry Moves Toward Greater Product Visibility

Pharmaceutical traceability is becoming an increasingly important part of packaging and supply-chain strategy in South Africa.

The South African Health Products Regulatory Authority (SAHPRA) published its Guideline on Traceability of Health Products in October 2025. The guideline establishes a framework for product identification, data capture and data sharing, with the objective of improving supply-chain visibility, product security and patient safety. 

More importantly for pharmaceutical manufacturers, SAHPRA’s implementation roadmap outlines a phased transition from batch-level identification to unit-level serialization across primary, secondary and tertiary packaging.

The implementation is therefore not simply a question of adding another barcode to a carton. Manufacturers need to consider the complete chain — identification, printing, code quality, verification, aggregation, master data and data exchange.

And the timing makes preparation particularly relevant.

SAHPRA’s roadmap identifies October 2026 as the industry-readiness assessment stage, followed by pre-implementation testing and data-sharing preparation in April 2027. Batch-level compliance for imported products is scheduled for October 2027, while domestic products have a later batch-level milestone of October 2029. Unit-level serialization follows in subsequent phases. Sahpra

What Is SAHPRA’s Traceability Framework?

SAHPRA’s Traceability Guideline provides a framework for implementing global standards for:

• Product identification
• Automatic data capture
• Data carriers
• Product data
• Packaging-level identification
• Data sharing
• Traceability across the pharmaceutical supply chain

The guideline applies broadly to health products regulated by SAHPRA, subject to the exclusions specified in the guideline. These include categories such as whole blood and blood components, certain homeopathic products, extemporaneous preparations, food and related supplements, investigational drugs and certain authorised imports. Sahpra

The underlying objective is straightforward: a pharmaceutical product should be identifiable and traceable through the supply chain, with machine-readable information supporting the movement of the product from manufacturing through distribution.

SAHPRA describes the framework as supporting end-to-end supply-chain visibility, supply-chain efficiency, supply security and patient safety. 

From Batch-Level Identification to Unit-Level Serialization

One of the most important aspects of the South Africa pharmaceutical serialization roadmap is that implementation is phased.

Phase 1: Batch-Level Identification — 2025 to 2029

The first phase focuses on identifying products using:

• GTIN
• Expiry date
• Batch/Lot number

Phase 2: Unit-Level Serialization — 2027 to 2031

The next stage adds a unique serial number to the product identifier.

This creates a unique identity for an individual product instance rather than identifying only a product type or batch.

This distinction is important for manufacturers planning their technology investments.

A line designed only to print a batch number today may not necessarily be ready for a future environment in which every saleable unit carries a unique serialized identity.

The right question is therefore not only “Can we print a code?” but “Can our complete packaging infrastructure support traceability as requirements evolve?”

What Does the SAHPRA Timeline Mean for Pharmaceutical Manufacturers?

SAHPRA’s published roadmap provides different milestones for imported and domestically manufactured products.

For primary and secondary packaging, the roadmap identifies:

The same roadmap also specifies requirements for tertiary trade items and logistics units, including the use of SSCC for logistics units from October 2030.

This phased approach means pharmaceutical companies should not wait until the final serialization milestone to begin evaluating their infrastructure.

There are several technology, validation and process decisions that need to happen well before a serialized product reaches the market.

What Information Needs to Be Encoded?

The SAHPRA roadmap identifies several key data elements.

GTIN — AI (01)

The Global Trade Item Number identifies the trade item.

Expiry Date — AI (17)

The expiry date is represented using the specified GS1 format.

Batch/Lot — AI (10)

The batch or lot number identifies the production batch.

Serial Number — AI (21)

The serial number provides the unique identity required for unit-level serialization.

SSCC — AI (00)

The Serial Shipping Container Code is used to identify logistics units such as pallets.

These elements are not simply data fields sitting inside a database. They need to be correctly generated, encoded, printed, captured and associated with the appropriate product and packaging hierarchy.

GS1 DataMatrix: Why It Matters

For pharmaceutical manufacturers, one of the most important technologies in this transition is the GS1 DataMatrix.

SAHPRA’s guideline identifies GS1 DataMatrix as a 2D data carrier that can be read by imaging scanners and vision systems.

Unlike a conventional linear barcode, a 2D code can accommodate multiple pieces of information within a relatively small footprint — an important consideration when applying traceability information to Pharmaceutical Packaging.

However, printing a DataMatrix is only one part of the process.

Manufacturers need to ensure that the code:

• Contains the correct data
• Uses the correct GS1 Application Identifiers
• Is printed in the correct location
• Remains readable at production speeds
• Meets required print-quality standards
• Can be successfully verified by the packaging-line vision system
• Is correctly associated with the product and batch data

SAHPRA’s implementation roadmap specifies a minimum barcode print-quality requirement of Grade C (1.5 or above) and references ISO/IEC 15416:2016 and ISO/IEC 15415:2011.

This makes code verification an important part of the compliance strategy — not an optional quality check.

Aggregation: The Part Manufacturers Should Not Overlook

Serialization is often discussed in terms of the individual carton or unit.

But traceability does not stop at the individual pack.

SAHPRA’s guideline defines aggregation as the relationship between parent and child packaging hierarchies. This allows a scan at a higher packaging level to establish what individual products or lower-level packages are contained within it.

For example:

Individual Pack → Bundle → Case → Pallet

A practical aggregation system therefore needs to maintain the relationship between these levels.

This has major implications for packaging-line design.

A manufacturer implementing serialization should ask:

Can we reliably establish and maintain the parent-child relationship between every packaging level?

If the answer is no, simply installing a serialization printer will not deliver end-to-end traceability.

Data Exchange Is Becoming Just as Important as Line-Level Serialization

Another important development is the increasing focus on the digital infrastructure behind traceability.

In September 2026, SAHPRA held an industry information session specifically covering digital systems, data exchanges and API interfaces for traceability implementation. The session addressed interoperability, data exchange standards, APIs and the technical considerations required for information sharing across the health-product supply chain. Sahpra

This is an important signal for manufacturers.

Traceability is not only a packaging-line project.

It involves collaboration between:

Packaging + QA + IT + Regulatory + Supply Chain + ERP/MES/serialization systems

The line needs to capture reliable information, while the software infrastructure needs to retain, manage and exchange that information appropriately.

What Pharma Companies in South Africa Should Start Evaluating Now

For companies preparing for SAHPRA traceability implementation, the following checklist is a useful starting point.

1. Review your current product identification

Identify how your products are currently coded at:

• Primary level
• Secondary level
• Tertiary level
• Logistics level

Then compare this with the future SAHPRA requirements.

2. Check your GS1 readiness

Manufacturers should review their:

• GTIN structure
• GLNs
• Packaging-level identifiers
• GS1 membership/status
• Application Identifier usage
• Data ownership and governance

The SAHPRA roadmap specifically identifies GS1 membership verification as part of the October 2026 industry-readiness stage. 

3. Evaluate your printers and coding systems

Can your existing equipment consistently print the required information?

Consider:

• Print resolution
• Line speed
• Code placement
• Substrate
• Ink/laser performance
• Changeover requirements
• Reject handling

A code that is technically generated but cannot be consistently read at production speed creates a very different problem.

4. Introduce robust code verification

This is where machine vision becomes critical.

Your inspection system should be capable of verifying:

Presence → Readability → Data correctness → Print quality

Rather than relying on an operator to periodically inspect samples, automated vision verification can check codes continuously on the packaging line.

5. Plan for aggregation

Do not treat aggregation as an afterthought.

Map your packaging hierarchy:

Primary → Secondary → Tertiary → Logistics

Then determine where aggregation relationships will be created, verified and stored.

6. Assess your serialization software

Your software environment should be capable of handling:

• Serial number generation
• Commissioning
• Decommissioning
• Product/batch relationships
• Aggregation
• Audit trails
• Data storage
• Line integration
• Enterprise integration
• Data exchange

The system architecture needs to be scalable enough to support the move from batch-level identification toward unit-level serialization.

7. Evaluate ERP/MES and external system integration

Traceability data should not become another isolated data silo.

Manufacturers should evaluate how serialization and packaging data will interact with existing:

• ERP
• MES
• WMS
• Production systems
• Quality systems
• Supply-chain systems

The objective should be interoperability, rather than simply adding another standalone software application.

8. Start validation and testing early

Serialization affects both hardware and software.

Before implementation, manufacturers should consider:

• FAT/SAT
• Installation qualification
• Operational qualification
• Performance qualification
• Software validation
• Data integrity
• User access controls
• Audit trails
• Change control
• Backup and recovery

The earlier these activities are incorporated into the project plan, the less disruptive the transition is likely to be.

9. Prepare your teams

Serialization changes the way multiple departments interact with production data.

Training should therefore extend beyond operators.

Relevant stakeholders can include:

• QA
• Production
• Packaging
• Engineering
• IT
• Regulatory Affairs
• Supply Chain
• Warehouse
• Validation

A technically capable system can still fail operationally if responsibilities and processes are unclear.

Common Mistakes to Avoid

Treating serialization as a printer project

A printer produces the code. It does not create an end-to-end traceability system.

Waiting until the deadline

The implementation timeline includes readiness assessment, testing, data-sharing preparation and trading-partner alignment before later compliance milestones. 

Ignoring aggregation

Serialization without reliable packaging hierarchy relationships can leave a major gap in supply-chain visibility.

Focusing only on code generation

The code must also be verified, captured, associated with the correct product and retained as usable data.

Building a closed system

Future traceability requirements increasingly depend on information moving between systems and trading partners. SAHPRA’s 2026 industry session specifically addressed digital systems, data exchanges and APIs. 

Treating every market requirement as identical

South Africa’s traceability framework has its own implementation dates and requirements. Manufacturers exporting to multiple markets should therefore design a system that can accommodate South African requirements alongside other serialization regimes, rather than assuming that one country’s implementation automatically satisfies another.

A Practical Readiness Framework for 2026

For pharmaceutical companies assessing their readiness today, a useful approach is to divide the project into five workstreams:

1. Identify

Establish GTINs, GLNs and the required product master data.

2. Encode

Determine how required information will be encoded into GS1-compliant data carriers.

3. Verify

Implement automated inspection to confirm that codes are present, readable, correctly encoded and of acceptable quality.

4. Aggregate

Create reliable parent-child relationships between primary, secondary, tertiary and logistics packaging.

5. Exchange

Ensure traceability information can move between relevant internal systems, trading partners and the regulatory ecosystem.

This approach helps move the conversation from “How do we comply?” to “How do we build a traceability architecture that can scale?”

What Should Pharma Manufacturers Do Now?

The most important takeaway from the SAHPRA roadmap is that pharmaceutical companies have a phased implementation path, but preparation needs to begin well before the final serialization dates.

For manufacturers, the immediate priorities should be:

✓ Conduct a traceability gap assessment
✓ Review GS1 identifiers and master data
✓ Evaluate current coding and inspection equipment
✓ Assess serialization and aggregation capabilities
✓ Review ERP/MES/IT integration
✓ Establish data governance requirements
✓ Begin readiness and testing activities
✓ Engage packaging, QA, IT and regulatory teams early

SAHPRA’s roadmap identifies October 2026 for industry readiness assessment, April 2027 for pre-implementation testing and data-sharing preparation, and October 2027 as the batch-level compliance milestone for imported products. 

That makes 2026 a practical planning and readiness window, rather than a year to wait for the final deadline.

How Jekson Vision Can Help

Preparing for SAHPRA traceability requires more than adding a serialization printer to an existing packaging line.

Jekson Vision provides integrated Track & Trace, serialization, aggregation and vision inspection solutions designed to connect the physical packaging process with the digital traceability layer.

Our solutions can support pharmaceutical manufacturers across:

Serialization | Code Verification | Vision Inspection | Aggregation | Line Integration | Track & Trace

From verifying GS1 DataMatrix codes on individual packs to establishing aggregation relationships across packaging levels, the objective is to create a traceability infrastructure that works reliably at production speed.

For manufacturers preparing for SAHPRA traceability requirements in South Africa, the right time to evaluate the packaging line, software architecture and data strategy is before implementation becomes a production constraint.

Talk to Jekson Vision about assessing your current packaging infrastructure and preparing for South Africa’s next phase of pharmaceutical traceability.

Connect at marketing@jeksonvision.com and Mobile + 91 6352529570

Primary

• SAHPRA traceability requirements
• SAHPRA traceability

Secondary

• SAHPRA serialization requirements
• South Africa pharmaceutical serialization
• pharmaceutical serialization South Africa
• SAHPRA serialization 2027
• pharmaceutical track and trace South Africa
• South Africa pharma traceability
• GS1 DataMatrix South Africa
• pharmaceutical aggregation
• SAHPRA track and trace

Long-tail opportunities

• What are SAHPRA traceability requirements?
• SAHPRA serialization requirements for pharmaceutical manufacturers
• South Africa pharmaceutical serialization timeline
• SAHPRA GS1 DataMatrix requirements
• South Africa pharmaceutical track and trace implementation
• SAHPRA traceability implementation 2026